EUVIMEDEUVIMED entdecken
Open Access

High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020–April 2021), Democratic Republic of the Congo

Yannick Munyeku-Bazitama, Gervais T Folefack, Marc K Yambayamba, Paul M Tshiminyi, Benito M Kazenza, John O Otshudiema, Noe Tondri Guinko, Moreau D Umba, Anastasie Mulumba, Lionel K Baketana, Patrick K Mukadi, Chris Smith und 3 weitere

Emerging Infectious Diseases · 2023

DOI: 10.3201/eid2901.221009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2023. Verfasst von Yannick Munyeku-Bazitama und 14 weiteren Autor:innen. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serologic surveys are important tools for estimating the true burden of COVID-19 in a given population. After the first wave of SARS-CoV-2 infections, a household-based survey conducted in Kinshasa, Democratic Republic of the Congo, estimated >292 infections going undiagnosed for every laboratory-confirmed case. To ascertain the cumulative population exposure in Kinshasa after the second wave of COVID-19, we conducted a prospective population-based cross-sectional study using a highly sensitive and specific ELISA kit. The survey included 2,560 consenting persons from 585 households; 55% were female and 45% male. The overall population-weighted, test kit-adjusted SARS-CoV-2 seroprevalence was 76.5% (95% CI 74.5%-78.5%). The seroprevalence was 4-fold higher than during the first wave, and positivity was associated with age, household average monthly income, and level of education. Evidence generated from this population-based survey can inform COVID-19 response, especially vaccination campaign strategies in the context of vaccine shortages and hesitancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19MaleFemaleHumansSARS-CoV-2Seroepidemiologic StudiesCross-Sectional StudiesDemocratic Republic of the CongoProspective StudiesAntibodies, Viral

Stichwörter der Autor:innen

COVID-19Democratic Republic of the CongoKinshasaSARS-CoV-2coronavirus diseaserespiratory infectionssecond waveseroprevalencesevere acute respiratory syndrome coronavirus 2vaccine-preventable diseasesviruseszoonoses

Substanzen

Antibodies, Viral

Zitieren

APA

Munyeku-Bazitama, Y., Folefack, G. T., Yambayamba, M. K., Tshiminyi, P. M., Kazenza, B. M., Otshudiema, J. O., Guinko, N. T., Umba, M. D., Mulumba, A., Baketana, L. K., Mukadi, P. K., Smith, C., Muyembe-Tamfum, J. J., Ahuka-Mundeke, S., & Makiala-Mandanda, S. (2023). High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020–April 2021), Democratic Republic of the Congo. Emerging Infectious Diseases. https://doi.org/10.3201/eid2901.221009

Vancouver

Munyeku-Bazitama Y, Folefack GT, Yambayamba MK, Tshiminyi PM, Kazenza BM, Otshudiema JO, et al. High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020–April 2021), Democratic Republic of the Congo. Emerging Infectious Diseases. 2023. doi:10.3201/eid2901.221009

BibTeX
@article{MunyekuBazitama2023,
  author = {Munyeku-Bazitama, Yannick and Folefack, Gervais T and Yambayamba, Marc K and Tshiminyi, Paul M and Kazenza, Benito M and Otshudiema, John O and Guinko, Noe Tondri and Umba, Moreau D and Mulumba, Anastasie and Baketana, Lionel K and Mukadi, Patrick K and Smith, Chris and Muyembe-Tamfum, Jean-Jacques and Ahuka-Mundeke, Steve and Makiala-Mandanda, Sheila},
  title = {High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020–April 2021), Democratic Republic of the Congo},
  journal = {Emerging Infectious Diseases},
  year = {2023},
  doi = {10.3201/eid2901.221009}
}
Kostenlos starten →